Saladax Biomedical
Three States OK Saladax to Offer MyCare Tests
NEW YORK (GenomeWeb News) – Saladax Biomedical on Thursday said that its Saladax Biomedical Laboratories division has received licenses from three states allowing it to provide its MyCare tests to clinicians in those states.
Chinese Pharma Company Fosun Invests $22.5 M into Saladax, Inks Distribution Deal
NEW YORK (GenomeWeb News) – Chinese pharmaceutical firm Fosun Pharma has made a $22.5 million investment into Saladax Biomedical, making it the largest shareholder in the assay development company.
Saladax, Transmedic Partner to Distribute Oncology Dosing Assays in Singapore, Hong Kong
NEW YORK (GenomeWeb News) – Saladax on Friday said that it has reached a distribution deal with Transmedic covering Saladax's MyCare oncology therapeutic dose management assays in Singapore and Hong Kong.
Saladax Regains Rights to My5-FU Assay from Myriad
NEW YORK (GenomeWeb News) – Saladax Biomedical today said that it will offer its My5-FU assay as part of its MyCare service offering later this year after regaining marketing rights to the test from Myriad Genetics.
In Brief This Week: Saladax Biomedical; Meridian Bioscience; Quest Diagnostics; Metabolon, Syngenta
NEW YORK (GenomeWeb News) – Saladax Biomedical said this week that it plans to open a CLIA lab at its headquarters in Bethlehem, Pa. The firm has applied for approval from both the State of Pennsylvania and the federal government and is targeting a launch next year.
Jun 15, 2012
People in the News: Jun 15, 2012
Jul 8, 2011
Movers & Shakers: Jul 8, 2011
Premium
Jun 21, 2011